Endurant Capital Management as of June 30, 2020
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 56 positions in its portfolio as reported in the June 2020 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Ishares Tr Rus 2000 Val Etf Put Option (IWN) | 85.2 | $1.6B | 109k | 14318.00 | |
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 1.3 | $24M | 78k | 308.35 | |
Oxford Immunotec Global Ord Shs | 1.0 | $18M | 1.4M | 13.00 | |
Evolent Health Note 2.000%12/0 | 1.0 | $18M | 20M | 0.88 | |
Si-bone (SIBN) | 0.6 | $12M | 743k | 15.94 | |
Johnson & Johnson (JNJ) | 0.6 | $12M | 84k | 140.63 | |
Centene Corporation (CNC) | 0.6 | $11M | 170k | 63.55 | |
Zoetis Cl A (ZTS) | 0.5 | $10M | 73k | 137.04 | |
Esperion Therapeutics (ESPR) | 0.5 | $9.4M | 183k | 51.31 | |
Encompass Health Corp (EHC) | 0.5 | $8.7M | 141k | 61.93 | |
Anthem (ELV) | 0.4 | $7.9M | 30k | 262.99 | |
Medtronic SHS (MDT) | 0.4 | $7.0M | 76k | 91.69 | |
Cigna Corp (CI) | 0.4 | $6.8M | 36k | 187.64 | |
ICU Medical, Incorporated (ICUI) | 0.4 | $6.6M | 36k | 184.30 | |
Laboratory Corp Amer Hldgs Com New | 0.3 | $6.3M | 38k | 166.11 | |
Ocular Therapeutix (OCUL) | 0.3 | $6.3M | 755k | 8.33 | |
Abbvie (ABBV) | 0.3 | $6.1M | 63k | 98.19 | |
Zimmer Holdings (ZBH) | 0.3 | $5.5M | 46k | 119.36 | |
Trillium Therapeutics Com New | 0.3 | $5.5M | 678k | 8.09 | |
HMS Holdings | 0.3 | $5.2M | 162k | 32.39 | |
Sanofi Sponsored Adr (SNY) | 0.3 | $5.1M | 100k | 51.05 | |
Selecta Biosciences | 0.3 | $5.1M | 1.8M | 2.84 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.3 | $4.8M | 483k | 10.01 | |
Hologic (HOLX) | 0.3 | $4.7M | 82k | 57.00 | |
Prothena Corp SHS (PRTA) | 0.2 | $4.2M | 404k | 10.46 | |
Hill-Rom Holdings | 0.2 | $3.9M | 36k | 109.79 | |
Insmed Com Par $.01 (INSM) | 0.2 | $3.9M | 140k | 27.54 | |
Boston Scientific Corporation (BSX) | 0.2 | $3.7M | 106k | 35.11 | |
Calliditas Therapeutics Ab Sponsered Ads | 0.2 | $3.7M | 160k | 23.20 | |
Baxter International (BAX) | 0.2 | $3.7M | 42k | 86.10 | |
Syneos Health Cl A | 0.2 | $3.2M | 55k | 58.25 | |
Molecular Templates | 0.2 | $3.2M | 230k | 13.79 | |
Aclaris Therapeutics (ACRS) | 0.2 | $2.8M | 1.7M | 1.62 | |
Haemonetics Corporation (HAE) | 0.1 | $2.6M | 29k | 89.57 | |
McKesson Corporation (MCK) | 0.1 | $2.4M | 16k | 153.43 | |
Mustang Bio | 0.1 | $2.4M | 769k | 3.18 | |
Universal Hlth Svcs CL B (UHS) | 0.1 | $2.2M | 24k | 92.89 | |
Iqvia Holdings (IQV) | 0.1 | $2.2M | 16k | 141.89 | |
Bristol Myers Squibb (BMY) | 0.1 | $2.1M | 36k | 58.79 | |
Fate Therapeutics (FATE) | 0.1 | $2.1M | 61k | 34.31 | |
Principia Biopharma | 0.1 | $1.8M | 30k | 59.78 | |
Bio Rad Labs Cl A (BIO) | 0.1 | $1.6M | 3.5k | 451.36 | |
Dentsply Sirona (XRAY) | 0.1 | $1.5M | 35k | 44.07 | |
Becton, Dickinson and (BDX) | 0.1 | $1.5M | 6.1k | 239.31 | |
Five Prime Therapeutics | 0.1 | $1.4M | 237k | 6.10 | |
Senseonics Hldgs Note 5.250% 2/0 | 0.1 | $1.3M | 1.5M | 0.84 | |
Sutro Biopharma (STRO) | 0.1 | $1.2M | 156k | 7.76 | |
Adapthealth Corp Com Cl A (AHCO) | 0.1 | $1.1M | 71k | 16.10 | |
Ptc Therapeutics I (PTCT) | 0.1 | $998k | 20k | 50.72 | |
Zogenix Com New | 0.0 | $799k | 30k | 27.02 | |
Tcr2 Therapeutics Inc cs | 0.0 | $591k | 39k | 15.35 | |
Insulet Corporation (PODD) | 0.0 | $479k | 2.5k | 194.32 | |
Alexion Pharmaceuticals | 0.0 | $466k | 4.1k | 112.34 | |
Genocea Biosciences Com New (GNCAQ) | 0.0 | $276k | 120k | 2.30 | |
Vaxcyte (PCVX) | 0.0 | $216k | 6.8k | 31.64 | |
Adc Therapeutics Sa SHS (ADCT) | 0.0 | $206k | 4.4k | 46.71 |